![]() Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. | ![]() Mirimus Mirimus is a company that specializes in biotech and preclinical CRO solutions based on genetical engineering. | ![]() Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | |||
Founding Date | Founding Date 2018 | Founding Date 2003 | Founding Date 2010 | Founding Date 2013 | Founding Date 2013 |
Type | Type Public | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Seattle, US HQ Cambridge, US South San Francisco, US | Locations Emeryville, US HQ Sao Paulo, BR | Locations Brooklyn, US HQ | Locations Cambridge, GB HQ | Locations Cambridge, US HQ Boulder, US Cambridge, US |
Employees | Employees 19441% decrease | Employees 1,0031% decrease | Employees 63 | Employees 1192% decrease | Employees 20816% increase |
Valuation ($) | Valuation ($) 840.9 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 256.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $269.8m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2025) |
Net income | Net income ($244.2m) (FY, 2025) | Net income ($543.4m) (FY, 2022) | Net income N/A | Net income N/A | Net income ($160.1m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 34m (about 7 years ago) | Latest funding round $ 2m (about 15 years ago) | Latest funding round $ 10m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 700m | Total funding raised $ 551.9m | Total funding raised N/A | Total funding raised $ 11.3m | Total funding raised $ 210m |

Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation.
View company
Mirimus is a company that specializes in biotech and preclinical CRO solutions based on genetical engineering.
View companyNuclera is a company that specializes in DNA synthesis.
View company
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company